# Doxecitin and Doxribthymine in Adult Subjects With Thymidine Kinase 2 (TK2) Deficiency

> **NCT06754098** · PHASE2 · RECRUITING · sponsor: **Cristina Domínguez González** · enrollment: 15 (estimated)

## Conditions studied

- Thymidine Kinase 2 (TK2 ) Deficiency
- Mitochondrial Myopathies

## Interventions

- **DRUG:** Doxecitine and Doxribtimine

## Key facts

- **NCT ID:** NCT06754098
- **Lead sponsor:** Cristina Domínguez González
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06754098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06754098, "Doxecitin and Doxribthymine in Adult Subjects With Thymidine Kinase 2 (TK2) Deficiency". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06754098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*